Taken together, PPAR-β/-δ is a critical player in the pathogenesis of the metabolic syndrome, and its ligands may provide useful agents for treating dyslipidemia, obesity, insulin resistance, and atherosclerosis. This evidence concerns the gene PPARD and metabolic syndrome.